Effect of Lactobacillus plantarum 299v on Colonic Fermentation and Symptoms of Irritable Bowel...
Sen, S.; Mullan, M.M.; Parker, T.J.; Woolner, J.T.; Tarry, S.A.; Hunter, J.O.
2004-10-10 00:00:00
A number of recent clinical trials have promoted the use of probiotic bacteria as a treatment for irritable bowel syndrome (IBS). The recent demonstration of abnormal colonic fermentation in some patients with this condition provides an opportunity for the objective assessment of the therapeutic value of these bacteria. This study was designed to investigate the effects of Lactobacillus plantarum 299V on colonic fermentation. We conducted a double-blind, placebo-controlled, cross-over, four-week trial of Lactobacillus plantarum 299V in 12 previously untreated patients with IBS. Symptoms were assessed daily by a validated composite score and fermentation by 24-hr indirect calorimetry in a 1.4-m3 canopy followed by breath hydrogen determination for 3 hr after 20 ml of lactulose. On placebo, the median symptom score was 8.5 [6.25–11.25 interquartile range (IQR)], the median maximum rate of gas production was 0.55 ml/min (0.4–1.1 IQR), and the median hydrogen production was 189.7 ml/24 hr (118.3–291.1 IQR). On Lactobacillus plantarum 299V the median symptom score was 8 (6.75–13.5 IQR), the median maximum rate of gas production 0.92 ml/min (0.45–1.5 IQR), and the median hydrogen production 208.2 ml/24 hr (146–350.9 IQR). There was no significant difference. Breath hydrogen excretion after lactulose was reduced by the probiotic (median at 120 min, 6 ppm; placebo, 17 ppm; P = 0.019). In conclusion, Lactobacillus plantarum 299V in this study did not appear to alter colonic fermentation or improve symptoms in patients with the irritable bowel syndrome.
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngDigestive Diseases and SciencesSpringer Journalshttp://www.deepdyve.com/lp/springer-journals/effect-of-lactobacillus-plantarum-299v-on-colonic-fermentation-and-pLUofo6JkZ

Abstract

A number of recent clinical trials have promoted the use of probiotic bacteria as a treatment for irritable bowel syndrome (IBS). The recent demonstration of abnormal colonic fermentation in some patients with this condition provides an opportunity for the objective assessment of the therapeutic value of these bacteria. This study was designed to investigate the effects of Lactobacillus plantarum 299V on colonic fermentation. We conducted a double-blind, placebo-controlled, cross-over, four-week trial of Lactobacillus plantarum 299V in 12 previously untreated patients with IBS. Symptoms were assessed daily by a validated composite score and fermentation by 24-hr indirect calorimetry in a 1.4-m3 canopy followed by breath hydrogen determination for 3 hr after 20 ml of lactulose. On placebo, the median symptom score was 8.5 [6.25–11.25 interquartile range (IQR)], the median maximum rate of gas production was 0.55 ml/min (0.4–1.1 IQR), and the median hydrogen production was 189.7 ml/24 hr (118.3–291.1 IQR). On Lactobacillus plantarum 299V the median symptom score was 8 (6.75–13.5 IQR), the median maximum rate of gas production 0.92 ml/min (0.45–1.5 IQR), and the median hydrogen production 208.2 ml/24 hr (146–350.9 IQR). There was no significant difference. Breath hydrogen excretion after lactulose was reduced by the probiotic (median at 120 min, 6 ppm; placebo, 17 ppm; P = 0.019). In conclusion, Lactobacillus plantarum 299V in this study did not appear to alter colonic fermentation or improve symptoms in patients with the irritable bowel syndrome.

Journal

Digestive Diseases and Sciences
– Springer Journals

Published: Oct 10, 2004

Recommended Articles

Loading...

References

Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome

Alun Jones, V; Mclaughlin, P; Shorthouse, M; Worman, E; Hunter, JO

Food intolerance and the irritable bowel syndrome

Nanda, R; James, R; Smith, H; Dudley, CR; Jewell, DP

Management of patients with food intolerance in irritable bowel syndrome: the development and use of an exclusion diet

Parker, TJ; Naylor, SJ; Riordan, AM; Hunter, JO

The fecal microbial population in the irritable bowel syndrome

Balsari, A; Ceccarelli, A; Dubini, F; Fesce, E; Poli, G

Microbiological studies on food intolerance

Bayliss, CE; Houston, AP; Alun-Jones, V

Recent Advances in Anaerobic Bacteriology

Bradley, HK; Bayliss, CE; Wyatt, GM

Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome

Bradley, HK; Wyatt, GM; Bayliss, CE; Hunter, JO

Abnormal colonic fermentation in irritable bowel syndrome

King, TS; Elia, M; Hunter, JO

Survival of Lactobacillus plantarum DSM 9843 and effect on the short chain fatty acid content in faeces after ingestion of ProViva rose-hip drink